Ebixa 10mg FC Tablet
PDF Leaflet Revision Date: 25 November 2005
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of moderately severe to severe Alzheimer's disease.
Dosage (summary)
Start with 5 mg daily, increase to 20 mg/day (10 mg twice daily) after 3 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy and lactation.
Key Drug Interactions
- L-dopa
- Dopaminergic agonists
- Anticholinergics
- Amantadine
- Barbiturates
- Neuroleptics
Contraindications
- Hypersensitivity
- Children under 18
Common side effects
- Agitation
- Dizziness
- Hallucination
- Insomnia
- Diarrhoea
Counselling Points
- Monitor drug intake by caregiver
- Avoid driving until effects are known
- Report any unusual side effects
Serious warnings
- Caution in severe renal impairment
- Monitor patients with epilepsy
Important Disclaimer
The Ebixa 10mg FC Tablet professional information leaflet below is the property of H Lundbeck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
